Announcements
- Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
- Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
- Enovis to Participate in Upcoming Investor Conferences
- Enovis Announces First Quarter 2024 Results
- Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
- Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Enovis Announces Fourth Quarter and Full Year 2023 Results
- Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
- Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
More ▼
Key statistics
On Monday, Enovis Corp (C520:DUS) closed at 42.00, 6.06% above its 52-week low of 39.60, set on Jul 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 42.40 |
---|---|
High | 42.60 |
Low | 42.00 |
Bid | 41.60 |
Offer | 42.40 |
Previous close | 42.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 54.85m |
Free float | 54.32m |
P/E (TTM) | -- |
Market cap | 2.60bn USD |
EPS (TTM) | -1.89 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 18:31 BST.
More ▼